Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
BAUDAX BIO Aktie jetzt für 0€ handeln |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MPH HEALTH CARE | 18,500 | -1,60 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
17.06.2025 / 16:27 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen | |
SOLIGENIX | 1,350 | 0,00 % | SOLIGENIX, INC.: Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results | PRINCETON, N.J., May 9, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing... ► Artikel lesen | |
CHARLOTTES WEB | 0,062 | -0,81 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports Shareholder Meeting Voting Results | LOUISEVILLE, Colo., June 13, 2025 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce... ► Artikel lesen | |
QUALIGEN THERAPEUTICS | 3,240 | -100,00 % | Qualigen Therapeutics ernennt Robert B. Lim zum Vorsitzenden des Prüfungsausschusses | ||
ACLARIS THERAPEUTICS | 1,289 | +4,41 % | Aclaris Therapeutics, Inc. - 8-K, Current Report | ||
ALLARITY THERAPEUTICS | 0,995 | 0,00 % | Allarity Therapeutics, Inc.: Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer | TARPON SPRINGS, Fla., June 27, 2025 -- Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib-a... ► Artikel lesen | |
AMPIO | - | - | Ampio Pharmaceuticals, Inc. - 8-K, Current Report | ||
AVENUE THERAPEUTICS | 0,454 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 19.03.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 19.03.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 19.03.2025ISIN NameGB00BMCBZL07 TRPL.PT.ENG.TRANS.... ► Artikel lesen | |
PETROS PHARMACEUTICALS | 0,066 | 0,00 % | Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company's Equity Position | NEW YORK, NY / ACCESS Newswire / June 25, 2025 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the... ► Artikel lesen | |
PROCESSA PHARMACEUTICALS | 0,198 | 0,00 % | Processa Pharmaceuticals: Kursziel von H.C. Wainwright auf 2 US-Dollar gesenkt | ||
PAINREFORM | 1,390 | 0,00 % | PainReform Ltd: PainReform Provides Year-End Business Update | TEL AVIV, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a specialty pharmaceutical company focused on the reformulation of established... ► Artikel lesen | |
CONDUIT PHARMACEUTICALS | 2,885 | 0,00 % | Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market | NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 22, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit" or the "Company"), a dynamic, multi-asset clinical stage, life science... ► Artikel lesen | |
BAYER | 26,580 | -1,46 % | EQS-PVR: Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Bayer Aktiengesellschaft
Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
23.06.2025... ► Artikel lesen | |
NOVO NORDISK | 59,49 | +1,43 % | Buy or Goodbye?: Hellofresh, Tesla, Novo Nordisk und Zalando - Die Analystenstimmen des Tages | © Foto: Steffen Trumpf/dpaHellofresh, Tesla, Novo Nordisk und Zalando: So bewerten Top-Analysten die Aktien. Ein Überblick.JPMorgan senkt das Kursziel für Hellofresh Die US-Bank JPMorgan hat das Kursziel... ► Artikel lesen | |
MERCK KGAA | 112,55 | -0,09 % | MilliporeSigma and "Abbott Elementary" Inspire Students' Curiosity With Hands-On STEM | NORTHAMPTON, MA / ACCESS Newswire / June 25, 2025 / Between September 2024 and April 2025, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, teamed up with... ► Artikel lesen |